Most Read Articles
Elvira Manzano, 6 days ago
Tisagenlecleucel, now US FDA approved, has made history as the first ever chimeric antigen receptor (CAR) T-cell therapy for B-cell precursor acute lymphoblastic leukaemia (ALL) – a breakthrough that has the potential to transform treatment for blood cancers that have not responded to standard therapies.
09 Feb 2017
The combination of previsit patient coaching sessions and a question prompt list (QPL) leads to better patient-oncologist communication in advanced cancer, a study shows.
16 Jun 2015
Anastrozole is more effective than tamoxifen in preventing breast cancer recurrence in postmenopausal women with ductal carcinoma in situ who have undergone lumpectomy and radiation therapy, a recent phase III randomized trial has shown.
Christina Lau, 09 May 2017

Treatment with osimertinib significantly improves symptoms in patients with advanced non-small-cell lung cancer (NSCLC), according to new data from the phase III AURA3 trial presented at the European Lung Cancer Conference (ELCC) 2017.

Neoadjuvant Treatment of Early Breast Cancer

14 Mar 2017
Over 20 leading surgical and medical oncologists from Singapore attended a dinner meeting on the Neoadjuvant treatment of early breast cancer (eBC). Co-chaired by Dr Veronique Tan (National Cancer Centre, Singapore) and Dr Elaine Lim (National Cancer Centre, Singapore), the meeting served as a platform to discuss the role of neoadjuvant therapy in eBC management. Guest speakers, Professor J. Michael Dixon OBE (Edinburgh Breast Unit, Western General Hospital, Edinburgh, United Kingdom) and Dr Rebecca Dent (National Cancer Centre, Singapore) shared their perspectives on the benefits of neoadjuvant therapy in different BC subtypes.
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Elvira Manzano, 6 days ago
Tisagenlecleucel, now US FDA approved, has made history as the first ever chimeric antigen receptor (CAR) T-cell therapy for B-cell precursor acute lymphoblastic leukaemia (ALL) – a breakthrough that has the potential to transform treatment for blood cancers that have not responded to standard therapies.
09 Feb 2017
The combination of previsit patient coaching sessions and a question prompt list (QPL) leads to better patient-oncologist communication in advanced cancer, a study shows.
16 Jun 2015
Anastrozole is more effective than tamoxifen in preventing breast cancer recurrence in postmenopausal women with ductal carcinoma in situ who have undergone lumpectomy and radiation therapy, a recent phase III randomized trial has shown.
Christina Lau, 09 May 2017

Treatment with osimertinib significantly improves symptoms in patients with advanced non-small-cell lung cancer (NSCLC), according to new data from the phase III AURA3 trial presented at the European Lung Cancer Conference (ELCC) 2017.